Merck Verdict Cut to $1.5 Million From $8 Million

A federal judge cut a jury award against Merck & Co. in a lawsuit over its Fosamax osteoporosis drug to $1.5 million from $8 million while upholding the verdict in the case.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.